<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02237404</url>
  </required_header>
  <id_info>
    <org_study_id>008WABELCMW2014A</org_study_id>
    <nct_id>NCT02237404</nct_id>
  </id_info>
  <brief_title>Economic Evaluation and Communication in Remote Monitoring of People With Pacemakers</brief_title>
  <official_title>Sustainability of Cardiology Services: Economic Evaluation and Communication in Remote Monitoring of People With Pacemakers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tromso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to estimate the outcomes in health and cost of the follow-up&#xD;
      of patients with pacemakers.&#xD;
&#xD;
      The initial hypothesize of this study is that remote monitoring of pacemaker will show a best&#xD;
      relation of outcomes in costs and effectiveness than the conventional follow-up in hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular Diseases are a major cause of global morbidity and mortality, being&#xD;
      responsible according to the World Health Organization of the 30% of overall mortality.&#xD;
&#xD;
      Since 2001 that the first pacemaker of remote monitoring was implanted in Europe, more than&#xD;
      300,000 pacemaker have been implanted around the world. Despite this sharp expansion, the&#xD;
      scientific evidence on economic evaluations of pacemaker with remote monitoring is very&#xD;
      limited, and in our knowledge, studies including informal costs have not been conducted.&#xD;
&#xD;
      In the field of cardiology, telemedicine allows consultations with patients through&#xD;
      monitoring systems and remote communication analyzing the ongoing heart rates of people with&#xD;
      pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy and&#xD;
      subcutaneous Holter. The use of remote monitoring may save time and efforts to both&#xD;
      healthcare professionals and patients, including their informal caregivers, reducing the&#xD;
      number of follow up visits to the hospital and reducing the associated costs with patient&#xD;
      follow-up, which will help to improve sustainability of healthcare services.&#xD;
&#xD;
      During the 06 months of study, the patients with implant of pacemakers of both groups will be&#xD;
      assessed of the same parameters, in 3 different moments (pre-implant and months 1, and 6&#xD;
      post-implantation).&#xD;
&#xD;
      Pacemakers that are going to be used in the project:&#xD;
&#xD;
        1. Remote monitoring group: Biotronik Estella SR-T and DR-T &amp; Biotronik Evia SR-T and DR-T.&#xD;
&#xD;
        2. Hospital monitoring group: St Jude Medical Endurity SR and DR &amp; Sorin Reply 200 SR and&#xD;
           DR.&#xD;
&#xD;
      The study will estimate: 1) The Clinical features of the patients. 2) The effectiveness&#xD;
      through of administration of Health-Related Quality of Life questionnaires and 3) Finally,&#xD;
      hospital and informal costs of patients with pacemakers will be estimated by the researches.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical features</measure>
    <time_frame>6 months</time_frame>
    <description>Selected variables from the medical history records:&#xD;
Gender&#xD;
Age&#xD;
Indication for the implantation of the pacemaker.&#xD;
Comorbidities&#xD;
Pharmacological treatment&#xD;
Vital signs&#xD;
Pacemaker parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>EuroQol-5Dimensions (EQ-5D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-Related Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>Minnesota Living With Heart Failure Questionnaire (MLHF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients with Adverse Events&#xD;
Type of Adverse Events diagnosed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consultations and Hospitalizations unscheduled</measure>
    <time_frame>6 months</time_frame>
    <description>Number of unscheduled visits and hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct costs</measure>
    <time_frame>6 months</time_frame>
    <description>Direct costs taken into account:&#xD;
Pacemakers' costs (device implanted)&#xD;
Hospitalizations' costs&#xD;
Consultations' costs (hospital)&#xD;
Prescribed medical transport's cost&#xD;
Health personnel costs&#xD;
Pharmaceutical costs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indirect cost</measure>
    <time_frame>6 months</time_frame>
    <description>Maintenance of the medical consultation (hospital):&#xD;
Electricity&#xD;
Cleaning&#xD;
Furniture&#xD;
Health fungible&#xD;
Equipment investment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Informal costs</measure>
    <time_frame>6 months</time_frame>
    <description>Costs related to the care and displacements of patients to hospital:&#xD;
Displacement costs to hospital&#xD;
Accommodation costs&#xD;
Cost of meals&#xD;
Costs for caregivers</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Hospital monitoring of pacemakers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients have to go to the hospital to be monitorized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remote monitoring of pacemakers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telemedicine System:&#xD;
Patients have not to go to the hospital to be monitorized</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemedicine System</intervention_name>
    <description>Telemedicine System is used in remote monitoring group</description>
    <arm_group_label>Remote monitoring of pacemakers</arm_group_label>
    <other_name>Patients are monitorized from hospital</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be 18 years of age&#xD;
&#xD;
          -  Have a pacemaker implanted&#xD;
&#xD;
          -  Understand and be able to properly perform self-monitoring at home&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Be participating in another study&#xD;
&#xD;
          -  Refuse to participate in the study&#xD;
&#xD;
          -  Have implanted a different cardiac device to the pacemaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nordland Hospital</name>
      <address>
        <city>Bodo</city>
        <state>Nordland</state>
        <zip>N - 8092</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>August 25, 2014</study_first_submitted>
  <study_first_submitted_qc>September 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2014</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tromso</investigator_affiliation>
    <investigator_full_name>Antonio Lopez Villegas</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <keyword>Follow-Up studies</keyword>
  <keyword>Biological Pacemakers</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Efficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

